Skip to main content
Erschienen in: Journal of Clinical Immunology 6/2013

01.08.2013 | Original Research

A Phenotypic Approach for IUIS PID Classification and Diagnosis: Guidelines for Clinicians at the Bedside

verfasst von: Ahmed Aziz Bousfiha, Leïla Jeddane, Fatima Ailal, Waleed Al Herz, Mary Ellen Conley, Charlotte Cunningham-Rundles, Amos Etzioni, Alain Fischer, Jose Luis Franco, Raif S. Geha, Lennart Hammarström, Shigeaki Nonoyama, Hans D. Ochs, Chaim M. Roifman, Reinhard Seger, Mimi L. K. Tang, Jennifer M. Puck, Helen Chapel, Luigi D. Notarangelo, Jean-Laurent Casanova

Erschienen in: Journal of Clinical Immunology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

The number of genetically defined Primary Immunodeficiency Diseases (PID) has increased exponentially, especially in the past decade. The biennial classification published by the IUIS PID expert committee is therefore quickly expanding, providing valuable information regarding the disease-causing genotypes, the immunological anomalies, and the associated clinical features of PIDs. These are grouped in eight, somewhat overlapping, categories of immune dysfunction. However, based on this immunological classification, the diagnosis of a specific PID from the clinician’s observation of an individual clinical and/or immunological phenotype remains difficult, especially for non-PID specialists. The purpose of this work is to suggest a phenotypic classification that forms the basis for diagnostic trees, leading the physician to particular groups of PIDs, starting from clinical features and combining routine immunological investigations along the way. We present 8 colored diagnostic figures that correspond to the 8 PID groups in the IUIS Classification, including all the PIDs cited in the 2011 update of the IUIS classification and most of those reported since.
Literatur
1.
Zurück zum Zitat Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front Immunol. 2011;2:54.PubMedCrossRef Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency. Front Immunol. 2011;2:54.PubMedCrossRef
2.
Zurück zum Zitat Parvaneh N, Casanova JL, Notarangelo LD, Conley ME. Primary immunodeficiencies: a rapidly evolving story. J Allergy Clin Immunol. 2013;131(2):314–23.PubMedCrossRef Parvaneh N, Casanova JL, Notarangelo LD, Conley ME. Primary immunodeficiencies: a rapidly evolving story. J Allergy Clin Immunol. 2013;131(2):314–23.PubMedCrossRef
3.
Zurück zum Zitat Ochs HD, Smith CIE, Puck JM. Primary immunodeficiency diseases: a molecular & cellular approach. 2nd ed. New York: Oxford University Press; 2007. Ochs HD, Smith CIE, Puck JM. Primary immunodeficiency diseases: a molecular & cellular approach. 2nd ed. New York: Oxford University Press; 2007.
4.
Zurück zum Zitat Casanova JL, Abel L. Primary immunodeficiencies: a field in its infancy. Science. 2007;317:617–9.PubMedCrossRef Casanova JL, Abel L. Primary immunodeficiencies: a field in its infancy. Science. 2007;317:617–9.PubMedCrossRef
5.
Zurück zum Zitat Notarangelo LD, Casanova JL. Primary immunodeficiencies: increasing market share. Curr Opin Immunol. 2009;21:461–5.PubMedCrossRef Notarangelo LD, Casanova JL. Primary immunodeficiencies: increasing market share. Curr Opin Immunol. 2009;21:461–5.PubMedCrossRef
6.
Zurück zum Zitat Conley ME, Notarangelo LD, Casanova JL. Definition of primary immunodeficiency in 2011: a “trialogue” among friends. N Y Acad Sci. 2011;1238:1–6.CrossRef Conley ME, Notarangelo LD, Casanova JL. Definition of primary immunodeficiency in 2011: a “trialogue” among friends. N Y Acad Sci. 2011;1238:1–6.CrossRef
7.
Zurück zum Zitat Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2012. doi:10.1007/s10875-012-9751-7.PubMed Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol. 2012. doi:10.​1007/​s10875-012-9751-7.PubMed
8.
Zurück zum Zitat de Vries E, European Society for Immunodeficiencies (ESID) members. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. 2012;167(1):108–19.PubMedCrossRef de Vries E, European Society for Immunodeficiencies (ESID) members. Patient-centred screening for primary immunodeficiency, a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. 2012;167(1):108–19.PubMedCrossRef
9.
Zurück zum Zitat Oliveira JB, Fleisher TA. Laboratory evaluation of primary immunodeficiencies. J Allergy Clin Immunol. 2010;125:S297–305.PubMedCrossRef Oliveira JB, Fleisher TA. Laboratory evaluation of primary immunodeficiencies. J Allergy Clin Immunol. 2010;125:S297–305.PubMedCrossRef
10.
Zurück zum Zitat Admou B, Haouach K, Ailal F, Benhsaien I, Barbouch MR, Bejaoui M, et al. Primary immunodeficiencies: diagnosis approach in emergent countries (African Society for Primary Immunodeficiencies). Immunol Biol Spec. 2010;25(5–6):257–65. Admou B, Haouach K, Ailal F, Benhsaien I, Barbouch MR, Bejaoui M, et al. Primary immunodeficiencies: diagnosis approach in emergent countries (African Society for Primary Immunodeficiencies). Immunol Biol Spec. 2010;25(5–6):257–65.
11.
Zurück zum Zitat Samarghitean C, Ortutay C, Vihinen M. Systematic classification of primary immunodeficiencies based on clinical, pathological, and laboratory parameters. J Immunol. 2009;183(11):7569–75.PubMedCrossRef Samarghitean C, Ortutay C, Vihinen M. Systematic classification of primary immunodeficiencies based on clinical, pathological, and laboratory parameters. J Immunol. 2009;183(11):7569–75.PubMedCrossRef
12.
Zurück zum Zitat Perreault S, Bernard G, Lortie A, Le Deist F, Decaluwe H. Ataxia-telangiectasia presenting with a novel immunodeficiency. Pediatr Neurol. 2012;46(5):322–4.PubMedCrossRef Perreault S, Bernard G, Lortie A, Le Deist F, Decaluwe H. Ataxia-telangiectasia presenting with a novel immunodeficiency. Pediatr Neurol. 2012;46(5):322–4.PubMedCrossRef
13.
Zurück zum Zitat Rohr J, Beutel K, Maul-Pavicic A, Vraetz T, Thiel J, Warnatz K, et al. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases. Haematologica. 2010;95(12):2080–7.PubMedCrossRef Rohr J, Beutel K, Maul-Pavicic A, Vraetz T, Thiel J, Warnatz K, et al. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases. Haematologica. 2010;95(12):2080–7.PubMedCrossRef
14.
Zurück zum Zitat Pessach I, Walter J, Notarangelo LD. Recent advances in primary immunodeficiencies: identification of novel genetic defects and unanticipated phenotypes. Pediatr Res. 2009;65(5 Pt 2):3R–12.PubMedCrossRef Pessach I, Walter J, Notarangelo LD. Recent advances in primary immunodeficiencies: identification of novel genetic defects and unanticipated phenotypes. Pediatr Res. 2009;65(5 Pt 2):3R–12.PubMedCrossRef
15.
Zurück zum Zitat Villa A, Sobacchi C, Notarangelo LD, Bozzi F, Abinun M, Abrahamsen TG, et al. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood. 2001;97(1):81–8.PubMedCrossRef Villa A, Sobacchi C, Notarangelo LD, Bozzi F, Abinun M, Abrahamsen TG, et al. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood. 2001;97(1):81–8.PubMedCrossRef
Metadaten
Titel
A Phenotypic Approach for IUIS PID Classification and Diagnosis: Guidelines for Clinicians at the Bedside
verfasst von
Ahmed Aziz Bousfiha
Leïla Jeddane
Fatima Ailal
Waleed Al Herz
Mary Ellen Conley
Charlotte Cunningham-Rundles
Amos Etzioni
Alain Fischer
Jose Luis Franco
Raif S. Geha
Lennart Hammarström
Shigeaki Nonoyama
Hans D. Ochs
Chaim M. Roifman
Reinhard Seger
Mimi L. K. Tang
Jennifer M. Puck
Helen Chapel
Luigi D. Notarangelo
Jean-Laurent Casanova
Publikationsdatum
01.08.2013
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 6/2013
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-013-9901-6

Weitere Artikel der Ausgabe 6/2013

Journal of Clinical Immunology 6/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.